Skip to main content
Premium Trial:

Request an Annual Quote

Improved Outcomes Software s GeneLinker Gold and Platinum 4.6, GeneGo s MetaDrug 1.0 and MetaCore, CueMol, E-Cell Simulation Environment, MWG Biotech s E-Commerce Website, and Rescentris CERF and CERF-Notebook


Improved Outcomes Software has released GeneLinker Gold and Platinum 4.6. The new releases are focused primarily on importing and analyzing protein biomarker data. A protein biomarker package that previously required a separate installation is now included in the software, and the software’s proteomics import scripts have also been improved. For gene expression data analysis, the company has added new data import scripts to handle Koadarray ratio and two-color data.

GeneGo has launched MetaDrug 1.0, a platform that combines software for predicting metabolites and over 40 ADME/tox properties with visualization and analysis of toxicogenomics and metabolomics data. MetaDrug can be used as a standalone product or together with MetaCore, GeneGo’s analytical platform.

CueMol, a molecular structure visualization program that operates on Windows, is available at CueMol supports molecular coordinates (PDB format), electron density (CCP4, CNS, and BRIX format), MSMS surface data, and GRASP electrostatic potential maps. It includes the QScript scripting language for batch operations.

Version 3.1.103 of the E-Cell Simulation Environment is available at New features include an improved session monitor, a model editor with a pathway viewer, and support for differential-algebraic equations.

MWG Biotech has launched an improved e-commerce website (, which includes new bioinformatics tools for designing primers, dual-labeled probes, and siRNAs. The website’s DNA sequencing allows customers to download and view their data online, and provides Phred quality reports and Blast analysis.

Rescentris has released version 2.2.1 of its CERF (Collaborative Electronic Research Framework) knowledge management platform. CERF is based on Web Ontology Language ontologies, and can be customized for specific research workflows. CERF 2.2.1 is also integrated with the company’s new CERF-Notebook, an electronic laboratory notebook module.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.